October 11, 2007 -- Aida Pharmaceuticals reported that Chinese officials have loosened restrictions on Etimicin Sulfate, the company’s new generation of aminoglycoside antibiotic. Etimicin Sulfate, the first antibiotic to be developed in China, is a broad spectrum antibiotic used for serious infections. In its various forms (powder, injection, infusion), the antibiotic provides all of Aida’s revenues. We look at the company and its main product...
